search
Back to results

Dulce Digital-Me: An Adaptive mHealth Intervention for Underserved Hispanics With Diabetes (DD-Me)

Primary Purpose

Diabetes Mellitus, Type 2

Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Dulce Digital
Dulce Digital-Me (Automated Delivery)
Dulce Digital-Me (Medical Assistant)
Sponsored by
Scripps Whittier Diabetes Institute
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Diabetes Mellitus, Type 2 focused on measuring Diabetes, mHealth, Medical Assistant, Automated, Adaptive Feedback, Self-Management Support, Hispanics, HbA1c, Cyberinfrastructure, Federally-Qualified Health Centers, Cost-Effectiveness, T2DM, Pay-for-Performance, Medication Adherence, LDL-C, Systolic Blood Pressure, Text Messaging

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  1. Self-identified Hispanic/Latino
  2. 18 years or older
  3. Registered patient of a Neighborhood Healthcare Clinic
  4. Diagnosed with T2DM (Type 2 Diabetes Mellitus)
  5. HbA1c ≥ 8.0% and/or SBP ≥ 160 mmHg, and/or LDL-C ≥ 100 mg/dL in the last 30 days

Exclusion Criteria:

  1. Severe illness precluding regular clinic visits
  2. Pregnant or lactating
  3. Type 1 or gestational diabetes
  4. Lack of minimal literacy
  5. Plans to relocate
  6. Severe auditory or visual problems
  7. Primary language other than Spanish or English
  8. Unwilling to carry a mobile phone

Sites / Locations

  • Scripps Mercy Chula Vista
  • Scripps Whittier Diabetes Institute

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm Type

Experimental

Experimental

Experimental

Arm Label

Dulce Digital

Dulce Digital-Me (Automated Delivery)

Dulce Digital-Me (Medical Assistant)

Arm Description

The first of the three arms of the parallel design: The group of participants randomly assigned to this arm of the study receives one-size-fits-all educational text messages, with patient monitoring and transmission of blood glucose values.

The second of the three arms of the parallel design: The group of participants randomly assigned to this arm of the study receives educational text messages, with patient monitoring and transmission of blood glucose values, plus personalized goal-setting and tailored feedback delivered via automated algorithm-driven messaging, incorporated into existing primary care team processes.

The third of the three arms of the parallel design: The group of participants randomly assigned to this arm of the study receives educational text messages, with patient monitoring and transmission of blood glucose values, plus personalized goal-setting and tailored feedback delivered by Medical Assistants, incorporated into existing primary care team processes.

Outcomes

Primary Outcome Measures

Glycosylated Hemoglobin (HbA1c); % units
Low-density lipoprotein-cholesterol (LDL-C); mg/dL units
Systolic blood pressure (SBP); mmHg units

Secondary Outcome Measures

Patient Assessment of Chronic Illness Care (PACIC) - patient-reported outcome
Chronic Illness Resources Survey (CIRS) - patient-reported outcome
Summary of Diabetes Self-Care Activities (SDSCA) - patient-reported outcome
Patient Activation Measure (PAM) - patient-reported outcome
Adherence to Refills and Medications Scale (ARMS) - patient-reported outcome

Full Information

First Posted
April 24, 2017
Last Updated
November 18, 2021
Sponsor
Scripps Whittier Diabetes Institute
Collaborators
University of California, San Diego, San Diego State University
search

1. Study Identification

Unique Protocol Identification Number
NCT03130699
Brief Title
Dulce Digital-Me: An Adaptive mHealth Intervention for Underserved Hispanics With Diabetes
Acronym
DD-Me
Official Title
Dulce Digital-Me: An Adaptive mHealth Intervention for Underserved Hispanics With Diabetes
Study Type
Interventional

2. Study Status

Record Verification Date
November 2021
Overall Recruitment Status
Completed
Study Start Date
June 22, 2017 (Actual)
Primary Completion Date
August 14, 2021 (Actual)
Study Completion Date
August 14, 2021 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Scripps Whittier Diabetes Institute
Collaborators
University of California, San Diego, San Diego State University

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
This study will compare Dulce Digital (i.e., the investigators' proven-effective combination of "one-size-fits-all" educational text messages and nurse monitoring of patient-transmitted blood glucose values) and Dulce Digital-Me (DD-Me), an adaptive/dynamic mHealth (mobile health) intervention that is tailored to individuals' needs and behavioral progress, in improving diabetes clinical control, adherence, and patient-provider communication in Hispanics - an at-risk, understudied population that experiences disparities in diabetes prevalence and outcomes. These striking disparities in the growing and aging US Hispanic population have taxed the US healthcare system, while significantly reducing quantity and quality of life for millions of individuals. By offering an innovative, scalable, and sustainable approach that seamlessly integrates several mHealth technologies into existing primary care team processes to improve the health of Hispanics (and eventually, other at-risk, underserved groups), DD-Me has strong potential to significantly impact public health.
Detailed Description
Individuals of low socioeconomic (SES) and ethnic minority status, including Hispanics, the largest U.S. ethnic minority group, are disproportionately affected by diabetes. Poor healthcare access and cultural barriers prevent optimal care, adherence, and clinical benefit, thus placing Hispanics at high risk for costly diabetes complications. The investigators' established academic-healthcare-community partnership has unique experience in developing and testing innovative, cost-effective, and sustainable chronic care interventions to reduce disparities and improve health in underserved communities. The investigators recently developed Dulce Digital (i.e., "one-size-fits-all" educational text messages, with nurse monitoring of patient-transmitted blood glucose values), which improved glycemic control across 6 months, relative to usual care in a recent randomized controlled trial (RCT) of N=126 Hispanic patients with poorly controlled type 2 diabetes (T2DM). The process evaluation for this trial indicated that Dulce Digital was both feasible and acceptable from patient and provider perspectives; however, patients expressed a preference for a more individualized intervention, and providers requested an even greater focus on health behavior change. Thus, the proposed RCT will examine the comparative effectiveness of Dulce Digital versus "Dulce Digital-Me" (DD-Me) in N=414 Hispanic adults of low SES with poorly controlled T2DM from Neighborhood Healthcare, a San Diego Federally-Qualified Health Center. Guided by patient and provider feedback, DD-Me includes Dulce Digital components plus personalized goal-setting and feedback that is responsive to the individual's needs and preferences. The DD-Me adaptive feedback component will be informed by the Resources and Support for Self-Management Model and Operant Conditioning Theory, and based on the individual's progress on intermediate behavioral targets (i.e., medication adherence assessed by wireless sensor; brief mobile phone-based assessments of diet, physical activity, stress). Feedback will be delivered via algorithm-driven automated messaging in 50% of DD-Me participants and by the care team medical assistant in the remaining half to determine the feasibility and acceptability (given the purported cultural relevance of interpersonal relationships in the Hispanic culture), and the comparative effectiveness and cost of each delivery method. Changes in indicators of diabetes clinical control [i.e., glycosylated hemoglobin (HbA1c) low density lipoprotein cholesterol (LDL-C), systolic blood pressure (SBP)], patient-provider communication, and patient adherence (i.e., to medication and other diabetes self-management behaviors) will be evaluated across twelve months. Thorough process and cost-effectiveness analyses will evaluate the scalability and sustainability potential of DD-Me. This comparative evaluation of two mHealth approaches will elucidate how technology can be integrated most effectively and efficiently within existing nurse-led chronic care approaches to meet the complex needs of underserved individuals with poorly controlled T2DM.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Diabetes Mellitus, Type 2
Keywords
Diabetes, mHealth, Medical Assistant, Automated, Adaptive Feedback, Self-Management Support, Hispanics, HbA1c, Cyberinfrastructure, Federally-Qualified Health Centers, Cost-Effectiveness, T2DM, Pay-for-Performance, Medication Adherence, LDL-C, Systolic Blood Pressure, Text Messaging

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Outcomes Assessor
Allocation
Randomized
Enrollment
310 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Dulce Digital
Arm Type
Experimental
Arm Description
The first of the three arms of the parallel design: The group of participants randomly assigned to this arm of the study receives one-size-fits-all educational text messages, with patient monitoring and transmission of blood glucose values.
Arm Title
Dulce Digital-Me (Automated Delivery)
Arm Type
Experimental
Arm Description
The second of the three arms of the parallel design: The group of participants randomly assigned to this arm of the study receives educational text messages, with patient monitoring and transmission of blood glucose values, plus personalized goal-setting and tailored feedback delivered via automated algorithm-driven messaging, incorporated into existing primary care team processes.
Arm Title
Dulce Digital-Me (Medical Assistant)
Arm Type
Experimental
Arm Description
The third of the three arms of the parallel design: The group of participants randomly assigned to this arm of the study receives educational text messages, with patient monitoring and transmission of blood glucose values, plus personalized goal-setting and tailored feedback delivered by Medical Assistants, incorporated into existing primary care team processes.
Intervention Type
Behavioral
Intervention Name(s)
Dulce Digital
Intervention Description
One-size-fits-all educational text messages, with patient monitoring and transmission of blood glucose values.
Intervention Type
Behavioral
Intervention Name(s)
Dulce Digital-Me (Automated Delivery)
Intervention Description
Educational text messages, with patient monitoring and transmission of blood glucose values, plus personalized goal-setting and tailored feedback delivered via automated algorithm-driven messaging, incorporated into existing primary care team processes.
Intervention Type
Behavioral
Intervention Name(s)
Dulce Digital-Me (Medical Assistant)
Intervention Description
Educational text messages, with patient monitoring and transmission of blood glucose values, plus personalized goal-setting and tailored feedback delivered by Medical Assistants, incorporated into existing primary care team processes.
Primary Outcome Measure Information:
Title
Glycosylated Hemoglobin (HbA1c); % units
Time Frame
12 months
Title
Low-density lipoprotein-cholesterol (LDL-C); mg/dL units
Time Frame
12 months
Title
Systolic blood pressure (SBP); mmHg units
Time Frame
12 months
Secondary Outcome Measure Information:
Title
Patient Assessment of Chronic Illness Care (PACIC) - patient-reported outcome
Time Frame
12 months
Title
Chronic Illness Resources Survey (CIRS) - patient-reported outcome
Time Frame
12 months
Title
Summary of Diabetes Self-Care Activities (SDSCA) - patient-reported outcome
Time Frame
12 months
Title
Patient Activation Measure (PAM) - patient-reported outcome
Time Frame
12 months
Title
Adherence to Refills and Medications Scale (ARMS) - patient-reported outcome
Time Frame
12 months
Other Pre-specified Outcome Measures:
Title
Cost Effectiveness using the United Kingdom Prospective Diabetes Study (UKPDS) Outcomes Model
Time Frame
12 months
Title
Pay for Performance (P4P) Clinical Metrics
Time Frame
12 months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Self-identified Hispanic/Latino 18 years or older Registered patient of a Neighborhood Healthcare Clinic Diagnosed with T2DM (Type 2 Diabetes Mellitus) HbA1c ≥ 8.0% and/or SBP ≥ 160 mmHg, and/or LDL-C ≥ 100 mg/dL in the last 30 days Exclusion Criteria: Severe illness precluding regular clinic visits Pregnant or lactating Type 1 or gestational diabetes Lack of minimal literacy Plans to relocate Severe auditory or visual problems Primary language other than Spanish or English Unwilling to carry a mobile phone
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Athena Philis-Tsimikas, MD
Organizational Affiliation
Scripps Whittier Diabetes Institute
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Linda Gallo, PhD
Organizational Affiliation
San Diego State University
Official's Role
Principal Investigator
Facility Information:
Facility Name
Scripps Mercy Chula Vista
City
Chula Vista
State/Province
California
ZIP/Postal Code
91910
Country
United States
Facility Name
Scripps Whittier Diabetes Institute
City
La Jolla
State/Province
California
ZIP/Postal Code
92037
Country
United States

12. IPD Sharing Statement

Citations:
PubMed Identifier
35090520
Citation
Philis-Tsimikas A, Fortmann AL, Godino JG, Schultz J, Roesch SC, Gilmer TP, Farcas E, Sandoval H, Savin KL, Clark T, Chichmarenko M, Jones JA, Gallo LC. Dulce Digital-Me: protocol for a randomized controlled trial of an adaptive mHealth intervention for underserved Hispanics with diabetes. Trials. 2022 Jan 28;23(1):80. doi: 10.1186/s13063-021-05899-x.
Results Reference
derived

Learn more about this trial

Dulce Digital-Me: An Adaptive mHealth Intervention for Underserved Hispanics With Diabetes

We'll reach out to this number within 24 hrs